Successful Transcatheter Closure of a Large Patent Ductus Venosus with the Amplatzer Vascular Plug II

Cho, Young Kuk; Chang, Nam Kyu; S., J.

doi:10.1007/s00246-009-9397-2

Cited by 28 publications

(22 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Type IIa shunts are unique in that spontaneous closure has been reported in at least 13 young children [4,12,13]. When persistent, endovascular closure using coils, plugs, and/or stents has proven successful for many children with PDV [9,14,15] and other isolated type IIa shunts [16,17]. Liver mobilization typically allows for ligation of type IIa shunts without liver resection when coiling is not possible [18][19][20].…”

Section: Type Iia Pss (Arising From a Portal Branch)mentioning

confidence: 97%

Management and classification of type II congenital portosystemic shunts

Lautz

Tantemsapya

Rowell

et al. 2011

Journal of Pediatric Surgery

116

121

View full text Add to dashboard Cite

Section: Type Iia Pss (Arising From a Portal Branch)mentioning

confidence: 97%

Management and classification of type II congenital portosystemic shunts

Lautz

Tantemsapya

Rowell

et al. 2011

Journal of Pediatric Surgery

116

121

View full text Add to dashboard Cite

“…In the embolization of arteries, which are high-flow vessels, migration of the AVP is very rare (7). Internal iliac artery embolization is one of the most commonly reported applications of the AVP in arterial embolization, because if a common iliac artery aneurysm extends to the common iliac artery bifurcation in a patient with or without abdominal aortic aneurysm, simply extending the endograft into the external iliac artery beyond the internal iliac artery orifice could result in type 2 endoleakage (8).…”

Section: Resultsmentioning

confidence: 99%

Applications of the Amplatzer Vascular Plug to various vascular lesions

Güneyli

Çınar²,

Bozkaya³

et al. 2013

Diagn Interv Radiol

View full text Add to dashboard Cite

The Amplatzer ® Vascular Plug (AVP) can be used to embolize medium-to-large high-flow vessels in various locations. Between 2009 and 2012, 41 AVPs (device size, 6-22 mm in diameter) were used to achieve occlusion in 31 patients (24 males, seven females) aged 9-92 years (mean age, 54.5 years). The locations and indications for embolotherapy were as follows: internal iliac artery embolization before stent-graft repair for aorto-iliac (n=6) and common iliac artery (n=3) aneurysms, subclavian artery embolization before stent-graft repair for thoracic aorta (n=3) and arcus aorta (n=1) aneurysms, brachiocephalic trunk embolization before stent-graft repair for a thoracic aorta aneurysm (n=1), embolization of aneurysms and pseudoaneurysms (n=5), embolization for carotid blow-out syndrome (n=3), closure of arteriovenous fistula (n=8), and closure of a portosystemic fistula (n=1). Of the 41 AVPs, 30 were AVP 2 and 11 were AVP 4. The mean follow-up duration was 4.7 months (range, 1-24 months). During follow-up, there was one migration, one insufficient embolization, and one recanalization. The remaining vascular lesions were successfully excluded from the circulation. The AVP, which can be used in a wide spectrum of pathologies, is easy to use and causes few complications. This essay presents our experience with the AVP. T he Amplatzer® Vascular Plug (AVP, AGA Medical Corp., Golden Valley, Minnesota, USA) is a good alternative to other embolic materials (1). The AVP has many advantages over embolic materials such as coils or glue. It is retractable, and it can be repositioned. Use of the AVP has cost advantages over other embolic materials. It can be used safely in trauma patients or in patients before endovascular aortic repair (EVAR). It ensures permanent occlusion, and its migration risk is less than for coils. The results of embolization with the AVP have been excellent (2), and no contraindications for its use have been reported (3). All four types of AVP have two components: a vascular plug and a delivery wire. The plugs have radiopaque platinum marker bands at both ends (4). The AVP 2 contains a more densely woven nitinol mesh and minimizes migration and recanalization (5). The AVP 4 is used mostly in small, tortuous vessels (6). The AVP is made of self-expanding material, and it returns to its original shape after release from the catheter. It has a long delivery cable, is preloaded in a loader, and is delivered through guiding catheters ranging from 5 to 8 F in size. The AVP is released by rotating the delivery cable counterclockwise.Thirty-one patients (24 males, seven females) aged 9-92 years (mean age, 54.5 years), who underwent percutaneous occlusion with the AVP at our hospital between 2009 and 2012, were evaluated retrospectively. Patients with any pathology involving AVP use for embolization were included in this study. Patients in whom only other embolic materials were used were excluded. The study was approved by the Institutional Review Board and consent was obtained from the patients before th...

show abstract

“…In these cases, ADO is not suitable and the use of coils bears a high risk of complications such as residual leakage or embolization of the coil. In spite of the use of AVPs on a large scale [10][11][12] , some reports have claimed that the use of an AVP is contraindicated for the large tubular-type of PDA 13) . In this case, we tried using a larger size of AVP than is generally recommended and that brought about packing of the PDA.…”

Section: Discussionmentioning

confidence: 99%

Use of an Amplatzer Vascular Plug to occlude a tubular type of patent ductus arteriosus

2009

View full text Add to dashboard Cite

= Abstract = Patent ductus arteriosus (PDA) is a common congenital heart defect. All PDAs, regardless of size or degree of symptoms, require occlusion. Transcatheter PDA occlusion features fewer complications than trans-thoracic closure. It is also more cost-effective and has an excellent occlusion rate. Therefore, transcatheter PDA occlusion is accepted as the standard treatment option for PDA. However, tubular-type PDAs are difficult to close with ordinary detachable coils or the Amplatzer Duct Occluder; thus, these lesions remain a challenge for transcatheter closure. We attempted to occlude a tubular-type PDA by using an oversized Amplatzer Vascular Plug, which allowed intraluminal packing of the ductus. By using this treatment method, PDA occlusion was achieved safely with an excellent final outcome. We suggest that this approach may be a good option for transcatheter closure of a tubular-type PDA. (Korean J Pediatr 2009;52:1035-1037

show abstract

Successful Transcatheter Closure of a Large Patent Ductus Venosus with the Amplatzer Vascular Plug II

Cited by 28 publications

References 11 publications

Management and classification of type II congenital portosystemic shunts

Management and classification of type II congenital portosystemic shunts

Applications of the Amplatzer Vascular Plug to various vascular lesions

Use of an Amplatzer Vascular Plug to occlude a tubular type of patent ductus arteriosus

Contact Info

Product

Resources

About